Clinical effect of robot-assisted radical cystectomy in bladder cancer

This study aimed to determine whether robot-assisted radical cystectomy (RARC) can accelerate recovery, improve pelvic lymph node dissection effects, and reduce serum tumor marker tumor specific growth factor (TSGF) levels in patients with bladder cancer.

A total of 96 patients with bladder cancer admitted to our hospital were recruited as the research participants. Among them, 43 patients who adopted radical cystectomy were enrolled in the control group (CG), and 53 patients treated with RARC were included in the research group (RG). The operation time, intraoperative blood loss, postoperative bowel recovery time, gastrointestinal function recovery, complication rate, clinical efficacy, changes of TSGF levels before and after operation, postoperative satisfaction and quality of life were observed.

Compared with the CG, patients in the RG experienced longer operation times (P<0.05), less intraoperative blood loss (P<0.05), and faster time to bowel recovery, anal exhaust, and anal defecation (P<0.05); moreover, the RG had a lower incidence rate of complications (P=0.025) and TSGF levels (P<0.05), higher effective cure rate (P=0.023) and satisfaction degree (P=0.048), as well as superior quality of life scores in six dimensions (P<0.05).

The application of RARC can accelerate the recovery of patients with bladder cancer, improve the pelvic lymph node dissection effects, and reduce the serum levels of tumor marker TSGF.